抑制MET通路增加了小细胞肺癌中化疗免疫疗法的疗效
Raúl Del Rey-Vergara1, Miguel Alejandro Galindo-Campos1, Pedro Rocha2
1Cancer Research Program, Hospital del Mar Research Institute, Barcelona, Spain.
Cell reports. Medicine
|June 21, 2025
概括
将MET抑制添加到化疗免疫治疗中,可以通过克服耐药性和增强特定患者群体的免疫反应,改善晚期小细胞肺癌 (SCLC) 的结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 免疫疗法是先进小细胞肺癌 (SCLC) 的第一线治疗方法,但患者的治疗结果仍然可以得到改善.
- 肝细胞生长因子 (HGF) 受体 (MET) 途径的激活与SCLC的化学抵抗和降低免疫疗法的疗效有关.
- 瘤微环境因素,如骨髓细胞透,可能导致治疗耐药性.
研究的目的:
- 研究MET抑制的潜力,以提高SCLC中化疗免疫疗法的疗效.
- 探索MET通路激活和瘤微环境在SCLC治疗耐药性中的作用.
- 在基于MET抑制剂的治疗策略中确定患者选择的生物标志物.
主要方法:
- 利用SCLC小鼠模型来评估MET抑制与化疗免疫治疗 (抗PD-L1) 的组合.
- 分析了治疗前的人类SCLC瘤样本,以检查免疫透物及其与治疗反应的相关性.
- 测量了血清HGF水平,并将它们与瘤表型和潜在的治疗益处相关联.
主要成果:
- 在SCLC小鼠模型中,将MET抑制与化疗免疫疗法结合起来,可以减少瘤生长和延长生存期.
- 这种组合疗法调节了瘤微环境,减少了抑制性髓状细胞,增强了免疫反应.
- 对人类样本的分析表明,富含髓质蛋白的透物与化学免疫疗法耐药性相关.
- 血清HGF水平升高与中酶体和炎症瘤表型有关.
结论:
- MET抑制是一种有前途的治疗策略,用于克服SCLC中化学免疫疗法耐药性.
- 向MET途径可以增强抗瘤免疫反应,并改善生物标志物定义的SCLC患者子集的结果.
- 生物标志物策略,包括血清HGF水平和瘤表型,可以指导那些可能受益于MET抑制剂治疗的患者的选择.
相关概念视频
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K


